NATICK, Mass., April 22 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX - News) today announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention (PCI) procedures. Guidewires are small flexible wires physicians use to deliver interventional devices such as drug-eluting stents. The Kinetix Guidewire features a unique micro-cut nitinol sleeve designed for significantly improved torque control compared to conventional spring coil guidewires. The Kinetix Guidewire represents the first major advance in coronary guidewire technology in nearly a decade. The Company will begin a phased launch of the Kinetix Guidewire immediately and expand to full product availability by next quarter.
